Hill (TSXV:HILL) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the space where craft consumer products meet bioscience by leveraging its deep CPG expertise to commercialize leading-edge technologies to craft superior consumer products. The company is currently developing the platform for North American distribution around its rights to use Lexaria Bioscience Corp.’s ground-breaking DehydraTECH patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

For more information, visit https://hillincorporated.com/.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Bear and bull statues wearing Christmas hats

@ the Bell: TSX advances to start off Christmas trading week

Canada’s TSX index closed higher on Monday thanks to large-cap gains, despite weakness in real estate and telecom stocks.

They started in video game investing, now they serve high net worth traders

Robertson Stephens Wealth Management recently acquired CAFG Private Wealth, a registered investment advisor managing over US$240 million
Doctor with a bladder replica

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide

As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.